Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?

SIMPLE SUMMARY: Glioblastoma is a type of brain cancer that remains incurable. Despite multiple past and ongoing preclinical studies and clinical trials, involving adjuvants to the conventional therapy and based on molecular targeting, no relevant benefit for patients’ survival has been achieved so...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilar, Juliana B., Christmann, Markus, Tomicic, Maja T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139489/
https://www.ncbi.nlm.nih.gov/pubmed/35626024
http://dx.doi.org/10.3390/cancers14102416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139489/
https://www.ncbi.nlm.nih.gov/pubmed/35626024
http://dx.doi.org/10.3390/cancers14102416

Ejemplares similares